IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Immunocellular Therapeutics

CUSIP: 452536204 | 42 institutional holders

Quarters

Q2 2020Q1 2019Q4 2018Q3 2018Q2 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2020

Captrust Financial Advisors25
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Captrust Financial Advisors
25$00.0%IndexLowRaleigh, NC2020-08-14